Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|May 11, 2012
Lactobacillus casei cell wall extract directly stimulates the expression of COX2 independent of Toll-like receptor 2 in rat glial cellsNaotoshi Sugimoto, Kunio Ohta, Takekatsu Saito, et al.
Frontiers in Pediatrics|August 30, 2024
Usefulness of deep sedation with intravenous dexmedetomidine and midazolam in cardiac catheterization procedures for pediatric patientsTaichi Nakamura, Hidenori Iwasaki, Hanae Miyazawa, et al.
Biochemical Pharmacology|June 28, 2016
Molecular basis for high affinity and selectivity of peptide antagonist, Bantag-1, for the orphan BB3 receptorTaichi Nakamura, Irene Ramos-Álvarez, Tatiana Iordanskaia, et al.
World Journal of Gastroenterology|November 26, 2008
Fractalkine and TGF-beta1 levels reflect the severity of chronic pancreatitis in humansMikihiko Yasuda, Tetsuhide Ito, Takamasa Oono, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 24, 2014
A sustained prostacyclin analog, ONO-1301, attenuates pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in ratsYusuke Niina, Tetsuhide Ito, Takamasa Oono, et al.
Peptides|November 3, 2015
Novel chiral-diazepines function as specific, selective receptor agonists with variable coupling and species variability in human, mouse and rat BRS-3 receptor cellsIrene Ramos-Álvarez, Taichi Nakamura, Samuel A Mantey, et al.
The Journal of Biological Chemistry|June 19, 2012
Crystal structure of the N-terminal domain of the yeast general corepressor Tup1p and its functional implicationsHiroyoshi Matsumura, Nanoha Kusaka, Taichi Nakamura, et al.
Peptides|January 3, 2015
ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growthTerry W Moody, Samuel A Mantey, Paola Moreno, et al.
Cancer Science|September 16, 2014
Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumorsMasayuki Hijioka, Tetsuhide Ito, Hisato Igarashi, et al.
Dermatology and Therapy|June 11, 2022
Efficacy and Safety of Apremilast in the Treatment of Patients with Mild-to-Moderate Psoriasis in Japan: Results from PROMINENT, A Phase 3b, Open-Label, Single-Arm StudyYukari Okubo, Hidetoshi Takahashi, Ryosuke Hino, et al.
Pageof 6